文献速递肾小球疾病

血清IgA的O-和N-糖基化与IgA肾病及肾小球功能相关

O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
PubMed 文献 · J Am Soc Nephrol · 2021-06-14

该横断面研究采用液相色谱-质谱法分析83例IgA肾病患者和244例年龄性别匹配健康对照的血清IgA胰蛋白酶糖肽,发现IgA1和IgA2的多种N-糖基化特征及IgA1的O-糖基化唾液酸化与IgA肾病和肾小球功能相关,且糖肽对疾病和肾功能的预测优于凝集素法检测的半乳糖缺陷型IgA1。

要点

  • IgA1和IgA2的N-糖基化特征与IgA肾病及肾小球功能相关
  • IgA1的O-糖基化唾液酸化与疾病和肾小球功能相关
  • 糖肽预测IgA肾病和肾功能优于凝集素法半乳糖缺陷型IgA1

核心结论

  • 高分辨率数据提示IgA的O-和N-糖肽是未来研究IgA肾病病理生理的有希望靶点,并可能作为疾病预测和肾功能恶化的无创生物标志物。

研究设计与样本

  • 横断面研究,采用液相色谱-质谱法分析血清IgA的胰蛋白酶糖肽,纳入83例IgA肾病患者和244例年龄性别匹配的健康对照。

主要发现

  • IgA1和IgA2的多种N-糖基化结构特征与IgA肾病和肾小球功能相关,包括半乳糖基化、唾液酸化、平分型、岩藻糖基化和N-糖链复杂度的差异。
  • IgA1的O-糖链唾液酸化与IgA肾病和肾小球功能均相关。
  • 糖肽对IgA肾病和肾小球功能的预测优于凝集素法ELISA检测的半乳糖缺陷型IgA1水平。

临床怎么用

  • 血清IgA糖肽可能作为无创生物标志物用于IgA肾病预测和肾功能评估,但需进一步验证。

局限性

  • 横断面设计无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide and is a leading cause of renal failure. The disease mechanisms are not completely understood, but a higher abundance of galactose-deficient IgA is recognized to play a crucial role in IgAN pathogenesis. Although both types of human IgA (IgA1 and IgA2) have several N-glycans as post-translational modification, only IgA1 features extensive hinge-region O-glycosylation. IgA1 galactose deficiency on the O-glycans is commonly detected by a lectin-based method. To date, limited detail is known about IgA O- and N-glycosylation in IgAN. METHODS: To gain insights into the complex O- and N-glycosylation of serum IgA1 and IgA2 in IgAN, we used liquid chromatography-mass spectrometry (LC-MS) for the analysis of tryptic glycopeptides of serum IgA from 83 patients with IgAN and 244 age- and sex-matched healthy controls. RESULTS: Multiple structural features of N-glycosylation of IgA1 and IgA2 were associated with IgAN and glomerular function in our cross-sectional study. These features included differences in galactosylation, sialylation, bisection, fucosylation, and N-glycan complexity. Moreover, IgA1 O-glycan sialylation was associated with both the disease and glomerular function. Finally, glycopeptides were a better predictor of IgAN and glomerular function than galactose-deficient IgA1 levels measured by lectin-based ELISA. CONCLUSIONS: Our high-resolution data suggest that IgA O- and N-glycopeptides are promising targets for future investigations on the pathophysiology of IgAN and as potential noninvasive biomarkers for disease prediction and deteriorating kidney function.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Dotz V, Visconti A, Lomax-Browne HJ, et al. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function. J Am Soc Nephrol. 2021. PMID: 34127537. doi:10.1681/ASN.2020081208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。